ANIK
Anika Therapeutics Inc
20.40$
+0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 37.9% | 42.0% | 23.0% | 36.0% | 33.1% | 32.3% | 10.0% | 5.7% | 2.8% | -1.5% | 4.5% | 9.9% | |
| 4.5% | 4.1% | 3.6% | 3.8% | 5.6% | 5.2% | 11.5% | 9.7% | 9.3% | 11.8% | 6.8% | 5.1% | |
| 1.5% | 2.4% | 3.3% | 5.1% | 10.5% | 5.3% | 4.1% | 7.5% | 9.2% | 12.6% | 11.0% | 8.9% | |
| -6.5% | 1.7% | 3.3% | 6.2% | 12.8% | 8.1% | 18.7% | -2.4% | 9.4% | – | – | – | |
| 3.6% | 3.2% | -15.3% | -2.1% | -3.0% | -5.8% | -10.3% | -10.0% | -7.6% | -10.0% | -10.9% | -0.7% | |
| 1.5% | 9.9% | 13.6% | 7.9% | 4.4% | 2.5% | 1.2% | 3.5% | 4.8% | 4.5% | 6.4% | 6.1% | |
| -7.9% | -32.5% | -6.5% | -11.0% | -47.6% | 34.6% | -54.6% | -2.1% | -4.8% | -4.5% | -7.0% | -0.4% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | 1.0% | 0.4% | 0.2% | – | – | – | |
| -6.0% | 1.2% | -24.2% | 0.3% | -28.4% | -26.2% | -0.2% | -0.3% | -0.6% | -4.1% | -9.1% | -8.4% | |
| – | – | – | -0.5% | -0.5% | -0.5% | -0.3% | -0.1% | -0.2% | 0.0% | 0.0% | – | |
| 5.0% | 2.1% | -22.6% | 0.3% | -27.4% | -7.1% | -2.9% | -4.6% | -3.1% | -5.2% | -10.6% | -9.4% | |
| 34.9% | 11.3% | -6.2% | 25.6% | -41.9% | 59.7% | -47.3% | -1.0% | -5.2% | -11.1% | -13.1% | 0.3% | |
| 36.4% | 32.1% | 9.5% | 28.1% | 28.7% | 29.8% | 8.8% | 2.2% | -2.0% | -6.0% | -1.9% | 3.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.